Medical Use
Synribo is a medication used to treat adults with specific forms of chronic myelogenous leukemia (CML) that are resistant to or have not improved after treatment with at least two tyrosine kinase inhibitors, a class of anticancer drugs. Additionally, Synribo is being researched for its potential in treating other cancers. It works by inhibiting certain proteins involved in cell growth, which may lead to the destruction of cancer cells. Synribo is classified as a plant alkaloid and a protein synthesis inhibitor. It is also known by the names homoharringtonine and omacetaxine mepesuccinate.
Warning & Precautions
Synribo may pose a risk to a fetus if administered to pregnant women. If a patient is pregnant or becomes pregnant while taking Synribo, she should be informed about the potential dangers to the fetus. It is unclear whether Synribo is excreted in breast milk, so breastfeeding while on this medication is not advised.
Documentation Availability
Documents required to import Synribo to India?
Synribo can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing Synribo around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the generic name for the trade name drug Synribo®?
The generic name for Synribo® is Omacetaxine Mepesuccinate.
Who manufactures Synribo®?
Synribo® is manufactured by TEVA Pharmaceuticals USA, Inc.
Is Synribo® approved by the FDA?
Yes, Synribo® received FDA approval in August 2015.
What is the dosage and form in which Synribo® is available?
Synribo® is available as a single-use vial containing 3.5 mg of omacetaxine mepesuccinate in lyophilized powder form.
How to order Synribo® online in India?
Synribo® can be ordered online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
